These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26176252)

  • 21. [HDL2 and HDL3 cholesterol in hepatic cirrhosis].
    Pacifico A; Cherchi GM; Deiana MG; Maioli M
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):199-205. PubMed ID: 6860495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma copeptin, a possible prognostic marker in cirrhosis.
    Moreno JP; Grandclement E; Monnet E; Clerc B; Agin A; Cervoni JP; Richou C; Vanlemmens C; Dritsas S; Dumoulin G; Di Martino V; Thevenot T
    Liver Int; 2013 Jul; 33(6):843-51. PubMed ID: 23560938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
    Kerbert AJ; Verbeke L; Chiang FW; Laleman W; van der Reijden JJ; van Duijn W; Nevens F; Wolterbeek R; van Hoek B; Verspaget HW; Coenraad MJ
    PLoS One; 2015; 10(9):e0138264. PubMed ID: 26378453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile.
    Santos J; Salgado P; Santos C; Mendes P; Saavedra J; Baldaque P; Monteiro L; Costa E
    Scand J Surg; 2014 Mar; 103(1):21-5. PubMed ID: 24177986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids changes in alcoholic & non-alcoholic cirrhotics.
    Manocha S; Gandhi BM; Dwivedi M; Bhargava DK
    Indian J Med Res; 1989 Feb; 90():55-61. PubMed ID: 2722217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
    Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
    Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin.
    Younossi ZM; Stepanova M; Estep M; Negro F; Clark PJ; Hunt S; Song Q; Paulson M; Stamm LM; Brainard DM; Subramanian GM; McHutchison JG; Patel K
    J Hepatol; 2016 Jan; 64(1):29-36. PubMed ID: 26341824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy.
    Franzese CJ; Bliden KP; Gesheff MG; Pandya S; Guyer KE; Singla A; Tantry US; Toth PP; Gurbel PA
    Am J Cardiol; 2015 May; 115(9):1204-11. PubMed ID: 25759102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy.
    Kuo YH; Chuang TW; Hung CH; Chen CH; Wang JH; Hu TH; Lu SN; Lee CM
    J Formos Med Assoc; 2011 Jun; 110(6):363-71. PubMed ID: 21741004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of lipid profile in a population of university students.
    de Freitas RW; de Araújo MF; Lima AC; Pereira DC; Alencar AM; Damasceno MM
    Rev Lat Am Enfermagem; 2013; 21(5):1151-8. PubMed ID: 24142225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Privitera G; Spadaro L; Marchisello S; Fede G; Purrello F
    Dig Dis Sci; 2018 Jan; 63(1):16-26. PubMed ID: 29177578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between lipid profile and severity of liver damage in cirrhotic patients.
    Ghadir MR; Riahin AA; Havaspour A; Nooranipour M; Habibinejad AA
    Hepat Mon; 2010; 10(4):285-8. PubMed ID: 22312394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.